Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity

Blood

Volumn 94, Issue 12, 1999, Pages 3968-3975

  Lozier, Jay N ^a   Metzger, Mark E ^a   Donahue, Robert E ^a   Morgan, Richard A ^a  

^a Bldg 10 ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; CYTOKINE; FIBRINOGEN; VIRUS VECTOR;

ACUTE PHASE RESPONSE; ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; GENE THERAPY; HEMOPHILIA B; HUMAN; HYPOFIBRINOGENEMIA; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY;

EID: 0032762405     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.3968     Document Type: Article

References (38)

1. Lozier JN, Metzger ME, Donahue RE, Morgan RA: The rhesus macaque as an animal model for hemophilia B gene therapy. Blood 93:1875, 1999
2. Lozier JN, Kessler CM. Clinical aspects and therapy of hemophilia, in Hoffman R, Benz E, Shattil S, Furie B, Cohen HJ (eds): Hematology, Principles and Practice (ed 3). New York, NY, Churchill-Livingstone, 1999, p 1883
3. Lozier JN, Brinkhouse KM: Gene therapy of hemophilia. JAMA 271:47, 1994
4. Connelly S, Gardner JM, McClelland A, Kaleko M: High-level tissue-specific expression of functional human factor VIII in mice. Hum Gene Ther 7:183, 1996
5. Connelly S, Gardner JM, Lyons RM, McClelland A, Kaleko M: Sustained expression of therapeutic levels of human factor VIII in mice. Blood 87:4671, 1996
6. Connelly S, Mount J, Mauser A, Gardner JM, Kaleko M, McClelland A, Lothrop CD Jr: Complete short-term correction of canine hemophilia A by in vivo gene therapy. Blood 88:3846, 1996
7. Connelly S, Andrews JL, Gallo AM, Kayda DB, Qian J, Hoyer L, Kadan MJ, Gorziglia MI, Trapnell BC, McClelland A, Kaleko M: Sutained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91:3273, 1998
8. Shirley PS, Gallo AM, Andrews JL, Smith TAG, Lillicrap D, Kaleko M, Connelly S: Evaluation of adenoviral vectors for treatment of hemophilia A: Demonstration of an unexpected, non-linear in vivo dose response. Blood 92:296a, 1998 (abstr, suppl 1)
9. Smith TAG, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397, 1993
10. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM: In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353, 1994
11. Fang B, Wang H, Gordon G, Bellinger DA, Read MS, Brinkhous KM, Woo SL, Eisensmith RC: Lack of persistence of E1-recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther 3:217, 1996
12. Walter J, You Q, Hagstrom JN, Sands M, High KA: Successful expression of human factor IX following repeat administration of an adenoviral vector in mice. Proc Natl Acad Sci USA 93:3056, 1996
13. Yao S-N, Farjo A, Roessler BJ, Davidson BL, Kurachi K: Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: Evidence for prolonged stability and activity of the transgene in liver. Viral Immunol 9:141, 1996
14. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM: Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 3:137, 1996
15. Yang Y, Su Q, Wilson JM: Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol 70:7209, 1996
16. Jooss K, Ertl HC, Wilson JM: Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J Virol 72:2945, 1998
17. Chirmule N, Hughes JV, Gao GP, Raper SE, Wilson JM: Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol 72:6138, 1998
18. Warrier I, Ewenstein BM, Koerper MA, Shapiro A, Key N, DiMichele D, Miller RT, Pasi J, Rivard GE, Sommer SS, Katz J, Bergmann F, Ljung R, Petrini P, Lusher JM: Factor IX inhibitors and anaphylaxis in hemophilia B. J Pediatr Hematol Oncol 19:23, 1997
19. Ewenstein BM, Takemoto C, Warrier I, Lusher J, Saidi P, Eisele J, Ettinger LJ, Di Michele D: Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood 89:1115, 1997
20. Santagostino E, Gringeri A, Mannucci PM: Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: The advantages of early intervention. Br J Haematol 104:22, 1999
21. Lozier JN, Yankaskas JR, Ramsey WJ, Chen L, Berschneider H, Morgan RA: Gut epithelial cells as targets for gene therapy of hemophilia. Hum Gene Ther 8:1481, 1997
22. Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, Fratantoni J, Green D, Hampton J, Hilgartner M, Levine P, Lazerson J, McMillan C, Penner J, Shapiro S, Shulman NR: Proceedings: A more uniform measure of factor VIII inhibitors. Thromb Diath Haemorrh 34:612, 1975
23. Villinger F, Brar SS, Mayne A, Chikkala N, Ansari AA: Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol 155:3946, 1995
24. Svensson EC, Black HB, Dugger DL, Tripathy SK, Goldwasser E, Hao Z, Chu L, Leiden JM: Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 8:1797, 1997
25. Loser P, Jennings GS, Strauss M, Sandig V: Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFkappaB. J Virol 72:180, 1998
26. Gauldie J, Richards C, Harnish D, Lansdorf P, Baumann H: Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251, 1987
27. Lieber A, He CY, Meuse L, Schowalter D, Kirillova I, Winther B, Kay MA: The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 71:8798, 1997
28. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448, 1999
29. Weiss G, Bogdan C, Hentze MW: Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 158:420, 1997
30. Guo ZS, Wang LH, Eisensmith RC, Woo SL: Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3:802, 1996
31. Wersto RP, Rosenthal ER, Seth PK, Eissa NT, Donahue RE: Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 72:9491, 1998
32. Morral N, Parks RJ, Zhou H, Langston C, Schiedner G, Quinones J, Graham FL, Kochanek S, Beaudet AL: High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha 1-antitrypsin with negligible toxicity. Nat Genet 18:180, 1998
33. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S: Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Hum Gene Ther 10:365, 1999
34. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA: Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5:56, 1999
35. Tripathy SK, Black HB, Goldwasser E, Leiden JM: Immune responses to transgene-encoded proteins limit the stability of gene expression after injections of replication-defective adenovirus vectors. Nat Med 2:545, 1996
36. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991, 1994
37. Jooss K, Yang Y, Fisher KJ, Wilson JM: Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 72:4212, 1998
38. Blomback B, Hanson LA, Winberg H: Plasma Proteins (translated from Swedish by D. Hogg). New York, NY, Wiley, 1975